Avricore Health Inc. is a listed company. Its insiders report their share dealings to SEDI. Over the twelve months to 18 October 2026, 23 filings were filed, from 7 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Across the 2,140 companies tracked on its exchange, the median is 12 filings; at 23 filings, this issuer sits above that mark.
There has been no open-market purchase by an insider of Avricore Health Inc. for at least a year. Half of the filings or more reach the SEDI feed on the day of the trade. The shorter that gap, the sooner other investors can see what insiders have done.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
23 of 23 declarations
Avricore Health Inc. is a Canadian company focused on the health sector. It specializes in developing innovative diagnostic and healthcare solutions.